Document is current
Any future updates will be listed below
-
Authors
Iida, Osamu https://orcid.org/0000-0001-6829-7304
Fujihara, Masahiko
Kawasaki, Daizo
Mori, Shinsuke
Yokoi, Hiroyoshi
Miyamoto, Akira
Kichikawa, Kimihiko
Nakamura, Masato
Ohki, Takao
Diaz-Cartelle, Juan
Müller-Hülsbeck, Stefan
Gray, William A.
Soga, Yoshimitsu
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02574481 at ClinicalTrials.govDocuments that mention this clinical trial
24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent
https://doi.org/10.1007/s00270-021-02901-6
Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents
https://doi.org/10.1007/s00270-019-02355-x
Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent
https://doi.org/10.1007/s00270-020-02693-1
- License Information
-
More Information
Article History
Received: 2 April 2021
Accepted: 15 June 2021
First Online: 7 July 2021
Declarations
:
: Osamu Iida reports consulting for Boston Scientific.Masahiko Fujihara reports consulting for Boston Scientific.Daizo Kawasaki reports consulting for Boston Scientific.Mori Shinsuke has no financial conflicts of interest to disclose.Hiroyoshi Yokoi reports consulting for Boston Scientific.Akira Miyamoto reports consulting for Boston Scientific.Kimihiko Kichikawa reports consulting for Boston Scientific.Masato Nakamura reports consulting for Boston Scientific.Takao Ohki reports consulting for Boston Scientific.Juan Diaz-Cartelle is an employee of and owns stock in Boston Scientific.William A. Gray serves as an advisor to Boston Scientific.Stefan Müller-Hülsbeck serves as a consultant and has received honoraria and travel grants from Boston Scientific, and has received fees from Terumo.Yoshimitsu Soga serves as an advisor to Boston Scientific.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was approved by the applicable Institutional Review Board (IRB), ethics committee, or research ethics board for each study site.
: Informed consent was obtained from all individual participants included in the study.
: For this type of study, consent for publication is not required.
